Pharmacokinetic (PK) model generated based on the single ascending dose (SAD) data and the first multiple ascending dose (MAD ...

Atopic dermatitis—the most common type of eczema—can look very different on darker skin tones. As someone living with the ...

Patients with atopic dermatitis had an increased risk of COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.

LEO Pharma has reported topline outcomes from the Phase IIb trial of temtokibart, a potential new treatment for atopic ...

Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

The incidence and prevalence of atopic dermatitis among older adults increased from 1990 to 2021, although age-standardized rates decreased.

Apogee Therapeutics, Inc. had promising results from its APG808 Phase 1b study show potential for every 2-month asthma ...

Ashley Lora joined an eczema clinical trial for DUPIXENT and paved the way for other Black women to try clinical trials.

Johnson & Johnson (J&J) has reported new data from the Phase III ICONIC-TOTAL trial, assessing icotrokinra in treating plaque ...

Initial studies of staphylococcal adhesion focused on binding to the extracellular matrix and plasma proteins. More recently, studies have investigated adhesins for human keratinocytes and their ...